0.6580
-0.0220
(-3.19%)
As of 2:58:34 PM EDT. Market Open.
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
71,075
--
139,165
218,060
Total Liabilities Net Minority Interest
53,477
--
33,518
32,631
Total Equity Gross Minority Interest
17,598
--
105,647
185,429
Total Capitalization
17,598
--
108,812
195,057
Common Stock Equity
17,598
--
105,647
185,429
Capital Lease Obligations
8,142
--
10,107
10,908
Net Tangible Assets
17,598
--
105,647
185,429
Working Capital
32,973
--
103,377
189,739
Invested Capital
17,598
--
115,479
195,057
Tangible Book Value
17,598
--
105,647
185,429
Total Debt
8,142
--
19,939
20,536
Share Issued
45,718.0520
27,607.6460
27,425.4470
27,358.3750
Ordinary Shares Number
45,718.0520
27,607.6460
27,425.4470
27,358.3750
12/31/2021 - 10/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INAB IN8bio, Inc.
0.1481
-3.01%
SNSE Sensei Biotherapeutics, Inc.
0.3053
-2.46%
MRSN Mersana Therapeutics, Inc.
0.2788
-8.17%
IOBT IO Biotech, Inc.
0.8537
-2.77%
CTMX CytomX Therapeutics, Inc.
0.5038
+0.70%
IMRX Immuneering Corporation
1.2200
-5.43%
RLYB Rallybio Corporation
0.2527
+1.08%
KTTA Pasithea Therapeutics Corp.
1.5750
+46.00%
SPRC SciSparc Ltd.
0.2700
-2.00%
ALXO ALX Oncology Holdings Inc.
0.4792
-7.62%